DANBURY, Conn., Dec. 12, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) will issue its fourth quarter fiscal year 2013 financial results on December 18, 2013. Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an update on the company's progress.
|December 18, 2013 schedule:|
|4:30 pm ET:||Fourth quarter fiscal year 2013 results will be distributed|
|4:45 pm ET:||Conference call participants should dial:|
|+1 (877) 303 - 8028 (United States) or|
|+1 (760) 536 - 5167 (International)|
|5:00 pm ET:||Conference call begins|
Interested parties may access a live audio webcast of the conference call in the investor section of Biodel's website at www.biodel.com. The audio webcast will be archived and available for replay through the website.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. Biodel's product candidates are developed by applying proprietary technologies to existing drugs in order to improve their therapeutic profiles. More information about Biodel is available at www.biodel.com.
CONTACT: John Graziano, +1 (646) 378 2942Source:Biodel Inc.